Innovative Medicines for Tuberculosis Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $750K
Latest Deal Amount
  • Investors
  • 2

Innovative Medicines for Tuberculosis General Information

Description

Developer of medicines for the treatment of tuberculosis. The company offers research and development services towards the causes of tuberculosis and its symptoms and also focuses on developing medicines to fight all forms of tuberculosis.

Contact Information

Website
www.im4tb.org
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Services
Other Industries
Drug Discovery
Primary Office
  • EPFL Innovation Park
  • Building I
  • CH-1015 Lausanne
  • Switzerland
+41 021 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Innovative Medicines for Tuberculosis Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 16-Mar-2015 $750K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Innovative Medicines for Tuberculosis’s complete valuation and funding history, request access »

Innovative Medicines for Tuberculosis Executive Team (1)

Name Title Board Seat Contact Info
Iain Old Operational Director
To view Innovative Medicines for Tuberculosis’s complete executive team members history, request access »

Innovative Medicines for Tuberculosis Board Members (7)

Name Representing Role Since
Gabriel Clerc Innovative Medicines for Tuberculosis Board Member 000 0000
Giampiero de Luca Innovative Medicines for Tuberculosis Board Member 000 0000
Laurent Fraisse Ph.D Innovative Medicines for Tuberculosis Board Member 000 0000
Laurent Nicod MD Innovative Medicines for Tuberculosis Board Member 000 0000
Stewart Cole Innovative Medicines for Tuberculosis Chairman of the Board 000 0000
You’re viewing 5 of 7 board members. Get the full list »

Innovative Medicines for Tuberculosis Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital Minority 000 0000 000000 0
EPFL Innovation Park Accelerator/Incubator 000 0000 000000 0
To view Innovative Medicines for Tuberculosis’s complete investors history, request access »